GlassScriptPhysician profile
Peter A Vevon
NPI 1992793558
$1,044.87
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.00 · 2020: $111 · 2021: $312 · 2022: $265 · 2023: $189 · 2024: $93.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $178.84 | 2021-2022 | |
| Kerecis Limited | $164.93 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $91.41 | 2020-2021 | |
| Smith+Nephew, INC. | $63.92 | 2021-2022 | |
| Intra-Sana Laboratories | $49.51 | 2021-2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Innocoll Pharmaceuticals Limited | $33.84 | 2021-2022 | |
| Davol INC. | $33.82 | 2020 | |
| Bk Medical Holding Company INC. | $32.95 | 2024 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Merit Medical Systems INC | $31.08 | 2021-2023 | Savi Scout |
| Zyla Life Sciences, INC. | $29.97 | 2019 | |
| Intuitive Surgical, INC. | $29.68 | 2023 | Da Vinci Surgical System |
| Acell, INC. | $29.25 | 2020 | |
| Ethicon US, LLC | $29.12 | 2020-2022 | |
| Medtronic, INC. | $28.23 | 2021-2022 | |
| Polynovo North America LLC | $26.76 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $22.65 | 2023 | Airseal |
| Bard Peripheral Vascular, INC. | $19.42 | 2021 | |
| Kci USA, INC. | $18.55 | 2019 | |
| Convatec INC. | $18.15 | 2022 | |
| Hologic Sales and Service, LLC | $18.07 | 2024 | Localizer, Trunode |
| Baxter Healthcare | $15.31 | 2022 | |
| Endogastric Solutions, INC | $15.03 | 2022 | |
| Novo Nordisk INC | $14.38 | 2022 | |
| Bioptics, INC. | $14.23 | 2019 | |
| La Jolla Pharmaceutical Company | $13.06 | 2023 | Xerava |
| Abbott Laboratories | $12.25 | 2019 | |
| Reshape Lifesciences INC. | $10.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Vevon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.